Storage and stability of reconstituted peptides

Once a lyophilized peptide is reconstituted it becomes far less stable than the dry powder, and the diluent, temperature, light exposure, and handling all influence how long the solution holds up.

Peptides ship as a freeze-dried (lyophilized) powder precisely because water is the medium in which they degrade fastest. The dry powder can be remarkably stable, but the moment it is reconstituted the clock starts, and four factors — diluent, temperature, light, and physical handling — determine how long the solution remains usable. This is an educational reference to those factors and to the in-use windows reported on product labels; it is not storage advice for any specific product.

Lyophilized versus reconstituted stability

Lyophilization removes the water that drives hydrolysis and other degradation reactions, which is why a sealed dry vial can be transported at room temperature and stored for long periods refrigerated. Reconstitution reverses that protection: in solution, peptide bonds are exposed to hydrolysis, oxidation, and aggregation. As a result the in-use window for a reconstituted vial is measured in days to a few weeks, where the dry powder is measured in months or longer.

Diluent choice changes the timeline

The most consequential choice is the diluent. Bacteriostatic water contains roughly 0.9% benzyl alcohol, a preservative that inhibits microbial growth and is what makes a multi-dose vial viable over a period of days. Sterile water and saline contain no preservative, so a vial reconstituted with them is intended for more immediate single use. The trade-off, diluent stability profiles, and the situations in which each is appropriate are covered in the dedicated diluent guide linked below.

Temperature, light, and agitation

• Temperature: reconstituted peptides are generally stored refrigerated at 2–8 °C. Freezing a reconstituted solution is usually discouraged because ice-crystal formation can damage the peptide.
• Light: many peptides are light-sensitive, so solutions are typically kept in the original vial and protected from prolonged light exposure.
• Agitation: vigorous shaking creates foam and shear forces that can denature a fragile peptide. The standard practice is to swirl gently and to add diluent slowly down the inner wall of the vial.

In-use windows are product-specific

Where a peptide has an FDA-approved product, the label states an in-use stability window — for several recombinant growth-hormone products, for instance, the refrigerated in-use period is documented as up to 28 days from first use. Research-grade material has no such label, so the figures that circulate (commonly two to four weeks refrigerated) are general expectations rather than validated stability data. The authoritative number, when one exists, is always the manufacturer's prescribing information.

Signs a solution has degraded

Visible cues that a reconstituted solution should not be used include cloudiness, visible particulates, or a colour change in what should be a clear solution — signs of aggregation or contamination. These are coarse indicators only; chemical degradation can occur without any visible change, which is why the in-use window exists in the first place. When in doubt, the conservative reading is to defer to the shortest documented window for the product class.